Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.

Kadara H, Fujimoto J, Yoo SY, Maki Y, Gower AC, Kabbout M, Garcia MM, Chow CW, Chu Z, Mendoza G, Shen L, Kalhor N, Hong WK, Moran C, Wang J, Spira A, Coombes KR, Wistuba II.

J Natl Cancer Inst. 2014 Mar;106(3):dju004. doi: 10.1093/jnci/dju004. Epub 2014 Feb 22.

PMID:
24563515
[PubMed - indexed for MEDLINE]
2.

Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling.

Kadara H, Shen L, Fujimoto J, Saintigny P, Chow CW, Lang W, Chu Z, Garcia M, Kabbout M, Fan YH, Behrens C, Liu DA, Mao L, Lee JJ, Gold KA, Wang J, Coombes KR, Kim ES, Hong WK, Wistuba II.

Cancer Prev Res (Phila). 2013 Jan;6(1):8-17. doi: 10.1158/1940-6207.CAPR-12-0290. Epub 2012 Oct 19.

PMID:
23087048
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.

Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.

J Pathol. 2006 Oct;210(2):192-204.

PMID:
16915569
[PubMed - indexed for MEDLINE]
4.

G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.

Fujimoto J, Kadara H, Garcia MM, Kabbout M, Behrens C, Liu DD, Lee JJ, Solis LM, Kim ES, Kalhor N, Moran C, Sharafkhaneh A, Lotan R, Wistuba II.

J Thorac Oncol. 2012 Dec;7(12):1747-54. doi: 10.1097/JTO.0b013e31826bb1ff.

PMID:
23154545
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.

Szymanowska-Narloch A, Jassem E, Skrzypski M, Muley T, Meister M, Dienemann H, Taron M, Rosell R, Rzepko R, Jarząb M, Marjański T, Pawłowski R, Rzyman W, Jassem J.

Adv Med Sci. 2013;58(2):196-206. doi: 10.2478/ams-2013-0025.

PMID:
24451080
[PubMed - indexed for MEDLINE]
6.

ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors.

Dasgupta P, Rizwani W, Pillai S, Davis R, Banerjee S, Hug K, Lloyd M, Coppola D, Haura E, Chellappan SP.

J Natl Cancer Inst. 2011 Feb 16;103(4):317-33. doi: 10.1093/jnci/djq541. Epub 2011 Jan 6.

PMID:
21212384
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.

Liu J, Lin Y, Yang H, Deng Q, Chen G, He J.

Tumour Biol. 2011 Dec;32(6):1113-21. doi: 10.1007/s13277-011-0211-4. Epub 2011 Jul 22.

PMID:
21779982
[PubMed - indexed for MEDLINE]
8.

Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.

Gjerstorff MF, Pøhl M, Olsen KE, Ditzel HJ.

BMC Cancer. 2013 Oct 8;13:466. doi: 10.1186/1471-2407-13-466.

PMID:
24103781
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.

Võsa U, Vooder T, Kolde R, Fischer K, Välk K, Tõnisson N, Roosipuu R, Vilo J, Metspalu A, Annilo T.

Genes Chromosomes Cancer. 2011 Oct;50(10):812-22. doi: 10.1002/gcc.20902. Epub 2011 Jul 11.

PMID:
21748820
[PubMed - indexed for MEDLINE]
10.

ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer.

Kabbout M, Garcia MM, Fujimoto J, Liu DD, Woods D, Chow CW, Mendoza G, Momin AA, James BP, Solis L, Behrens C, Lee JJ, Wistuba II, Kadara H.

Clin Cancer Res. 2013 Jul 1;19(13):3383-95. doi: 10.1158/1078-0432.CCR-13-0341. Epub 2013 May 9.

PMID:
23659968
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene.

Wu M, Tu T, Huang Y, Cao Y.

BMC Cancer. 2013 Feb 1;13:44. doi: 10.1186/1471-2407-13-44.

PMID:
23374247
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.

PMID:
23756108
[PubMed - indexed for MEDLINE]
13.

Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers.

Lam DC, Girard L, Ramirez R, Chau WS, Suen WS, Sheridan S, Tin VP, Chung LP, Wong MP, Shay JW, Gazdar AF, Lam WK, Minna JD.

Cancer Res. 2007 May 15;67(10):4638-47.

PMID:
17510389
[PubMed - indexed for MEDLINE]
Free Article
14.

Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.

Jeong Y, Xie Y, Xiao G, Behrens C, Girard L, Wistuba II, Minna JD, Mangelsdorf DJ.

PLoS Med. 2010 Dec 14;7(12):e1000378. doi: 10.1371/journal.pmed.1000378.

PMID:
21179495
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Methylation markers of early-stage non-small cell lung cancer.

Lokk K, Vooder T, Kolde R, Välk K, Võsa U, Roosipuu R, Milani L, Fischer K, Koltsina M, Urgard E, Annilo T, Metspalu A, Tõnisson N.

PLoS One. 2012;7(6):e39813. doi: 10.1371/journal.pone.0039813. Epub 2012 Jun 29.

PMID:
22768131
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.

Tan D, Deeb G, Wang J, Slocum HK, Winston J, Wiseman S, Beck A, Sait S, Anderson T, Nwogu C, Ramnath N, Loewen G.

Diagn Mol Pathol. 2003 Dec;12(4):201-11.

PMID:
14639106
[PubMed - indexed for MEDLINE]
17.

Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer.

Zhang HT, Chen XF, Wang MH, Wang JC, Qi QY, Zhang RM, Xu WQ, Fei QY, Wang F, Cheng QQ, Chen F, Zhu CS, Tao SH, Luo Z.

Clin Cancer Res. 2004 Apr 1;10(7):2359-67.

PMID:
15073112
[PubMed - indexed for MEDLINE]
Free Article
18.

Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.

Skrzypski M, Dziadziuszko R, Jassem E, Szymanowska-Narloch A, Gulida G, Rzepko R, Biernat W, Taron M, Jelitto-Górska M, Marjański T, Rzyman W, Rosell R, Jassem J.

Clin Lung Cancer. 2013 Nov;14(6):666-673.e2. doi: 10.1016/j.cllc.2013.04.010. Epub 2013 Jul 17.

PMID:
23870818
[PubMed - indexed for MEDLINE]
19.

Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation.

Lo Iacono M, Monica V, Saviozzi S, Ceppi P, Bracco E, Papotti M, Scagliotti GV.

J Transl Med. 2011 Jun 30;9:100. doi: 10.1186/1479-5876-9-100.

PMID:
21718475
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Screening and identification of distant metastasis-related differentially expressed genes in human squamous cell lung carcinoma.

Wang N, Zhou F, Xiong H, Du S, Ma J, Okai I, Wang J, Suo J, Hao L, Song Y, Hu J, Shao S.

Anat Rec (Hoboken). 2012 May;295(5):748-57. doi: 10.1002/ar.22441. Epub 2012 Mar 15.

PMID:
22419659
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk